Pharma Focus Asia
KP - Choose our fully recyclable blister films

Pear Therapeutics Developed reSET-A™ PDT Product Candidate for Alcohol Use Disorder (AUD)

Pear therapeutics developed new reSET-A™ PDT product candidate for the treatment of alcohol use disorder (AUD)

PDTsare new therapeutic class designed with software to directly treat disease. Similar to traditional medicines, PDT’s are developed and tested in a randomized controlledtrials and demonstrates safety and effectiveness.

Currently, there are few treatment options for AUD patients with less than 2 percent of patients receiving medication for treating AUD.There are no FDA approved prescribed digital therapeutics or medical devices available for people with AUD-only.

In U.S, alcohol is one of the most commonly consumed substance. According to the survey, it was stated that in the year 2019 around 14 million U.S population including adults aging 18 and older had AUD. Moreover, alcohol related problems has affected approximately 95,000 people’s life leading them to deaths and thus made alcohol as the third main leading cause of death in United States.

U.S. Food and Drug Administration (FDA) grants Breakthrough Therapy designation for reSET-A™ PDT product candidateto treat alcohol use disorder (AUD).

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS